{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-011452","form_type":"8-K","ticker":"ABEO","cik":"0000318306","company_name":"ABEONA THERAPEUTICS INC.","filed_at":"2025-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.928074+00:00","generated_at":"2026-05-21T02:18:51.535207+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Abeona Therapeutics holds annual meeting; elects three Class 3 directors","bullets":["Mark J. Alvino, Faith L. Charles, and Donald A. Wuchterl elected as Class 3 directors.","Alvino received 26,260,868 votes for, Charles 26,774,705, Wuchterl 26,856,990.","Advisory vote on NEO compensation approved: 25,777,223 for, 1,552,881 against.","Ratification of Deloitte & Touche as auditor for FY 2025 approved: 34,334,516 for.","All proposals passed with broker non-votes on director election and say-on-pay."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-011452","json":"https://secwatch.observer/filing/0001641172-25-011452.json","markdown":"https://secwatch.observer/filing/0001641172-25-011452.md","text":"https://secwatch.observer/filing/0001641172-25-011452.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/318306/000164117225011452/0001641172-25-011452-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/318306/000164117225011452/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T02:18:51.535207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}